baber/WOPTO huggingface dataset:
Patent JP-2901794-B2 (JP)
IPC: A01N33/12
Filed: 1991-09-11
Granted: 1999-06-07
Abstract: A herbicidal composition is disclosed, comprising, as active ingredients, 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl )urea or a salt thereof and at least one member selected from the group consisting of N-(phosphonomethyl)glycine, 1,1'-dimethyl-4,4'-bipyridinium ion, 1,1'-ethylene-2,2'-bipyridylium ion and salts thereof.
Patent JP-2809767-B2 (JP)
IPC: C12Q1/04
Filed: 1989-12-01
Granted: 1998-10-15
Abstract: A diagnostic media and assay, as further described herein, for detecting fungicide resistant strains of fungal plant pathogens.
Patent JP-2778964-B2 (JP)
IPC: C22B43/00
Filed: 1988-12-12
Granted: 1998-07-23
Abstract: To remove, in particular, elemental Hg from waste waters (effluent) from battery factories, from chlor-alkali electrolysis and from electroplating plants, a suitable preliminary stage is their oxidising treatment with H2O2 in the presence of readily available and cheap compounds of iron or iodine which, as catalysts, enable the reaction of Hg with H2O2 to give a precipitatable Hg compound within an acceptable time for practical operation. After precipitation of the Hg as a relatively insoluble compound and filtration, the waste water solution is brought into contact with MnO2, excess H2O2 decomposing to give H2O and O2, and then led to a Hg-selective ionexchanger, which traps any residual quantities of Hg. Water thus detoxified is not burdened with significantly any byproducts formed during the treatment.
Patent JP-H0375590-B2 (JP)
IPC: C10G67/02
Filed: 1987-12-18
Abstract: Prior to upgrading a viscous feed by visbreaking, at least a portion of the feed is treated to remove a heavy phase in specified amounts, whereby the severity of the visbreaking may be increased. The Shell Hot Filtration number of the visbreaking product is reduced by at least 75%, compared to visbreaking of untreated feed at the same severity.
Patent JP-H0416452-B2 (JP)
IPC: C07C31/40
Filed: 1987-12-22
Abstract: The invention relates to the preparation of 1,1,2,2-tetrahydroperfluoroalkanols and their esters. A 2-(perfluoroalkyl)ethyl iodide is oxidized using peroxomonosulphuric acid or peroxodisulphuric acid in a carboxylic acid or carboxylic acid ester.
Patent JP-4584371-B2 (JP)
IPC: A24D3/02
Filed: 1998-11-20
Granted: 2010-11-17
Abstract: The method involves passing the strip (9) through a guide channel whilst constricting it to form a chord of filter material which is finally enclosed by an envelope strip (24). Filter rods are cut from the chord. Compressed gas, preferably compressed air, fed into the strip during constriction emanates downstream in an air outlet zone. A further gas flow, preferably air is blown into the filter strip upstream of the outlet zone and the air emanates through channels in another downstream outlet zone. An Independent claim is also included for an arrangement for carrying out the method.
Patent JP-H0645580-B2 (JP)
IPC: C07C319/20
Filed: 1991-10-23
Abstract: PCT No. PCT/US91/07608 Sec. 371 Date Apr. 22, 1993 Sec. 102(e) Date Apr. 22, 1993 PCT Filed Oct. 23, 1991.A process for preparing a compound of formula (IV):    <IMAGE>  (IV)  comprising a) contacting an oxazoline compound of formula (I):    <IMAGE>  (I)  wherein Z is as defined hereinbefore, with a reagent capable of causing an equilibrium between oxazoline compound (I) and an oxazoline compound of formula (II) described herein, and the reagent drives the equilibrium toward oxazoline compound (II) by preferential precipitation of oxazoline compound (II); b) contacting compound (II) with a fluorinating agent to give a fluorinated oxazoline compound of formula (III) described herein; and c) hydrolyzing the compound of formula (III) to formula (IV). In an alternative embodiment, the process is directed toward a process for preparing oxazoline (II) in a single step.
Patent JP-H0568305-B2 (JP)
Inventor: ORTEGA DE LA ORDEN VINCENT
IPC: B02C17/18
Filed: 1986-01-27
Abstract: PCT No. PCT/BE86/00003 Sec. 371 Date Oct. 6, 1986 Sec. 102(e) Date Oct. 6, 1986 PCT Filed Jan. 27, 1986 PCT Pub. No. WO86/04526 PCT Pub. Date Aug. 14, 1986.A device which regulates the retention time of material ground in a grinding mill is disclosed. The device comprises a cylindrical casing, a wall in the casing having a plurality of apertures therethrough, a reservoir chamber defined between the wall and a side of the casing, lifting structure in the reservoir chamber, and a reservoir scoop spaced from the casing and extending into the resevoir chamber. The discharge scoop comprises a hollow longitudinal member including a first opening on its upper surface and a second opening on its lower surface, with the openings being spaced longitudinally from each other.
Patent JP-3058347-B2 (JP)
IPC: D04H18/02
Filed: 1992-07-01
Granted: 2000-07-04
Abstract: PCT No. PCT/FR92/00612 Sec. 371 Date Dec. 30, 1993 Sec. 102(e) Date Dec. 30, 1993 PCT Filed Jul. 1, 1992 PCT Pub. No. WO93/01340 PCT Pub. Date Jan. 21, 1993.Two laps are needled together between longitudinal guide tubes which maintain spacing between the laps and downstream of the needling position, the tubes release an interleaving material between the laps and between the rows of bridges formed by needling, the interleaving material consisting of resin, powder, fibers, tubes, wires, threads, and/or electrical conductors.
Patent JP-H0725897-B2 (JP)
IPC: C08K5/54
Filed: 1990-02-08
Abstract: PCT No. PCT/NO90/00033 Sec. 371 Date Oct. 8, 1991 Sec. 102(e) Date Oct. 8, 1991 PCT Filed Feb. 8, 1990 PCT Pub. No. WO90/09407 PCT Pub. Date Aug. 23, 1990.Method for production of a thermostable crosslinked halogen-containing polymer. Expoxygroups are added by way of a monomer as for example glycidylmethacrylate. The crosslinking of the polymer is carried out through an organic silane which can be hydrolyzed. By this method the crosslinking can be separated from the processing of the polymer as it is catalyzed by moisture after the processing is carried out. The crosslinking reaction is carried out very fast. Good thermostability is gained even if the halogen-containing monomer is vinylchloride.
Patent JP-2542320-B2 (JP)
IPC: B21D26/02
Filed: 1992-01-31
Granted: 1996-10-09
Abstract: PCT No. PCT/DE92/00060 Sec. 371 Date Sep. 23, 1992 Sec. 102(e) Date Sep. 23, 1992 PCT Filed Jan. 31, 1992 PCT Pub. No. WO92/13653 PCT Pub. Date Aug. 20, 1992.A hollow workpiece having a tubular end portion is deformed by first fitting the workpiece into a die formed with a cavity adapted to receive the workpiece with the end portion of the workpiece projecting along an axis out of the die and then engaging over the projecting end portion of the workpiece a feed sleeve in a pressure-tight fit. The sleeve and workpiece are supported relative to each other such that the holding portion can slide in the sleeve and that the sleeve exerts substantially no axial force on the workpiece. Then an interior of the workpiece is pressurized through the sleeve and to deform the workpiece outward against an inner surface of the die.
Patent JP-3498146-B2 (JP)
IPC: C07B61/00
Filed: 1994-07-13
Granted: 2004-02-16
Abstract: PCT No. PCT/FR94/00880 Sec. 371 Date Jan. 16, 1996 Sec. 102(e) Date Jan. 16, 1996 PCT Filed Jul. 13, 1994 PCT Pub. No. WO95/02576 PCT Pub. Date Jan. 26, 1995A process for the preparation of N-carbonylarylimine of the general formula I:    <IMAGE>  I  in which Ar represent an aryl radical and R represent a phenyl or t-butoxy radical, by desulphonating the compound of the general formula II.    <IMAGE>  II  The compounds of formula II are novel when R is t-butoxy.
Patent JP-2677438-B2 (JP)
IPC: A61K39/395
Filed: 1989-06-08
Granted: 1997-11-17
Abstract: Cytotoxic compositions and methods for their use are provided for preventing proliferation of remnant lens epithelial cells following extracapsular extraction. The cytotoxic compositions comprise monoclonal antibodies specific for lens epithelial cells which are introduced into the anterior chamber of the eye where they bind specifically to any lens epithelial cells. The method may be used at the time of extracapsular cataract extraction or may be used subsequently to remove a second cataract resulting from proliferation of remnant lens epithelial cells.
Patent JP-H07115801-B2 (JP)
IPC: B65H73/00
Filed: 1988-11-25
Abstract: To remove the thread waste (11) on a yarn carrier (7), the latter is clamped in a loading station (A) of the device between a take-up cone (6) and a pressing cone (8) arranged on a carriage (3) which slides to and fro on a carriage guide (1). During this movement, the yarn carrier (7) first passes through a cutting station (B) in which the thread waste (11) on the yarn carrier (7) is cut by blades (13) arranged on a blade head (12). During the subsequent movement of the yarn carrier (7), the pressing cone (8) is detached from the latter and the take-up cone (6) is set in rotation by a drive pulley (10) connected to a drive. The rotating yarn carrier (7) passes through a stripping station (C) into which compressed air is blown obliquely to the yarn carrier (7) through compressed air nozzles (15) arranged on a blower (14). The cut thread waste (11) is stripped and sucked through a suction channel (16). In a subsequent ejection station (D), the yarn carrier (7) is thrust away from the take-up cone (6) by an ejection cylinder (17) and the carriage (3) returns to the loading station (A) to begin a new work cycle.
Patent JP-H0832242-B2 (JP)
IPC: C07H21/04
Filed: 1991-04-22
Abstract: Methods for modulating the expression of the HIV +E,uns tat+EE  gene are disclosed comprising contacting tat RNA with oligonucleotide or oligonucleotide analog which can bind with at least a portions of the RNA. In accordance with the preferred embodiments, oligonucleotides or oligonucleotide analogs are designed to bind to portions of the tat RNA which are of significance to the expression of the gene coding for said RNA. In accordance with a preferred embodiment, methods of treatment of human immunodeficiency virus are disclosed.
Patent JP-3307936-B2 (JP)
IPC: G06V10/42
Filed: 1992-10-10
Granted: 2002-07-29
Abstract: A system for rapid and automatic identification of persons, with very high reliability and confidence levels. The iris of the eye is used an optical fingerprint, having a highly detailed pattern that is unique for each individual and stable over many years. Image analysis algorithms find the iris in a live video image of a person's face, and encode its texture into a compact signature, or "iris code." Iris texture is extracted from the image at multiple scales of analysis by a self-similar set of quadrature (2-D Gabor) bandpass filters defined in a dimensionless polar coordinate system. The sign of the projection of many different parts of the iris onto these multi-scale quadrature filters, determines each bit in an abstract (256-byte) iris code. The degrees-of-freedom in this code are based on the principle forms of variation in a population of irises studied. Because of the universal mathematical format and constant length of the iris codes, comparisons between them are readily implemented by the Exclusive-OR (XOR) logical operation. Pattern recognition is achieved by combining special signal processing methods with statistical decision theory, leading to a statistical test of independence based on a similarity metric (the Hamming distance) that is computed from the XOR of any two iris codes. This measure positively establishes, confirms, or disconfirms, the identity of any individual. It also generates an objective confidence level associated with any such identification decision.
Patent JP-3174336-B2 (JP)
IPC: A61J3/02
Filed: 1993-01-22
Granted: 2001-06-11
Abstract: Water dispersible granules suitable for agricultural application are prepared by first preparing absorbent water dispersible granules and then loading biologically active substances into the preformed absorbent granules.
Patent JP-2892156-B2 (JP)
IPC: E21B21/00
Filed: 1990-10-31
Granted: 1999-05-17
Abstract: PCT No. PCT/NO90/00164 Sec. 371 Date May 6, 1992 Sec. 102(e) Date May 6, 1992 PCT Filed Oct. 31, 1990 PCT Pub. No. WO91/07566 PCT Pub. Date May 30, 1991.A pressure converter for a drill pipe includes a housing with a header channel therein which is in communication with a drill bit, a drive unit which is driven by a driving drilling fluid flow of the drill pipe, a valve which is operatively connected to and moved by the drive unit, a piston which moves in a reciprocating manner thereby creating a pressure stroke and a return stroke, and a check valve through which a portion of the drilling fluid flow is discharged to the drill bit via the header channel. The reciprocating movement of the piston is controlled by the valve and the piston includes a first piston area which is subjected to the driving drilling fluid flow during the pressure stroke and which is in communication with a returning drilling fluid flow running outside the drill pipe, a second piston area which is opposite the first piston area and which is in communication, during the pressure stroke and the return stroke, with the returning drilling fluid flow, and a third piston area which is opposite to and smaller than the first piston area, and which 1) during the pressure stroke, generates an increased pressure in a portion of the driving drilling fluid flow, and 2) is in communication with the driving drilling fluid flow during the return stroke. The increased pressure portion of the driving drilling fluid flow is discharged via the first check valve and the header channel to the drill bit.
Patent JP-3450011-B2 (JP)
IPC: A61J1/00
Filed: 1995-12-13
Granted: 2003-09-22
Abstract: A needleless injector cartridge has an adaptor for introducing fluid from a filling device into an orifice of the cartridge. The adaptor has a frangible connection which is broken to allow removal of the filling device after the cartridge is filled with the fluid.
Patent JP-3032302-B2 (JP)
IPC: A61K31/34
Filed: 1996-11-12
Granted: 2000-04-17
Abstract: Substituted tetrahydrofuran analogs of F-series prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed.
Patent JP-4278715-B2 (JP)
IPC: H01S3/06
Filed: 1998-01-28
Granted: 2009-06-17
Abstract: A laser parametric generator for surgical applications is disclosed which utilizes short-pulse, mid-infrared radiation. The mid-infrared radiation may be produced by a pump laser source (20), such as a neodymium-doped laser, which is parametrically downconverted in a suitable nonlinear crystal (15) to the desired mid-infrared range. The short pulses reduce unwanted thermal effects and changes in adjacent to potentially submicron levels. The parametrically converted radiation source preferably produces pulse durations shorter than 25 ns at or near 3.0  mu m but preferably close to the water absorption maximum associated with the tissue. The down-conversion to the desired mid-infrared wavelength is preferably produced by a nonlinear crystal (15) such as KTP or its isomorphs. In one embodiment, a non-critically phased-matched crystal is utilized to shift the wavelength from a near-infrared laser source emitting at or around 880 to 900 nm to the desired 2.9 to 3.0  mu m wavelength range. A fiber, fiber bundle or another waveguide means utilized to separate the pump laser from the optical parametric oscillation (OPO) cavity is also included as part of the invention.
Patent MD-2189-B2 (MD)
Title: Method for stimulating the growth of fur-producing animals
Inventor: RUDIC VALERIU
IPC: A23K20/195
Filed: 2001-07-30
Abstract: The invention relates to zootechny, in particular to a process for stimulating the growth of fur-producing animals. The method for stimulating the growth of fur-producing animals includes addition into the animals feed of the culture liquid of streptomycete Streptomyces massasporeus CNM-AM-36, that is introduced into the feed once a day during a month, namely: in the I ten-day period for 0,8...1,2 ml, in the II ten-day period for 1,3...1,7 ml and in the III ten-day period for 1,8...2,2 ml to a feed portion. The result of the invention consists in increasing the live mass of the fur-producing animals and in reducing the death rate of the newborn animals. Claims: 1
Patent ES-2253066-B2 (ES)
Title: Procedimiento y dispositivo de regulacion y compensacion de campo magnetico de alta frecuencia en el nucleo magnetico de un acoplamiento inductivo de señal.
Inventor: ERCILLA LEGARRA LUCIO
IPC: H04B5/00
Filed: 2004-03-15
Granted: 2007-03-16
Abstract: La presente invención se refiere a un dispositivo (14) que permite regular el flujo magnético heterogéneo que se produce en el núcleo de un acoplamiento de señal inductivo debido a los flujos de fugas existentes. Su objetivo es reducir las pérdidas de inserción debidas a los flujos de fugas del acoplamiento mediante la homogeneización del flujo en toda la longitud del circuito magnético. La clave de esta invención consiste en la captación del flujo magnético en cada punto del núcleo mediante una serie de espiras abiertas que rodean el núcleo y que generan distintas tensiones U1 y U2 según el flujo que las atraviesa. Estas espiras conectadas en un circuito paralelo (14) consiguen comparar los flujos magnéticos de distintas zonas del núcleo, y crear una intensidad I (15) que genera unos flujos reguladores (16) y (17) que recomponen homogéneamente el campo magnético de alta frecuencia creado por la señal.
Patent ES-2288384-B2 (ES)
Inventor: VECIANA I MEMBRADO JOSE MARIA
IPC: A23G9/22
Filed: 2005-12-16
Granted: 2008-08-16
Abstract: It incorporates an upper disc (1) into which the containers (3) are inserted; this is linked to a lower disc (4) by means of an internal cylinder (10) which rotates with regard to a fixed external support (11) whereon accessories (12) related with the substances to be dispensed rest. The lower disc (4) rotates intermittently, bringing about the rotary movement and halting of the containers (3) in correspondence with the different dispensing heads (6), which supply the substances from the containers (12). The fixed external support (11) rests on a baseplate (13) and is comprised of an external cylinder (14) with regard to which the internal cylinder (10) rotates, radial arms (16) projecting from the external cylinder (14) and whereon vertical supports (17) are mounted, these being linked to an upper crown (18), which is located around the upper disc (1), and whereon the accessories (12) are attached.
Patent ES-2506490-B2 (ES)
Title: Procedimiento de fabricación de material metálico de alta porosidad en condiciones de imponderabilidad
Inventor: MONTES MARTOS JUAN MANUEL
IPC: B22F3/11
Filed: 2013-04-12
Granted: 2015-03-31
Abstract: Esta invención propone un nuevo procedimiento de fabricación de material metálico de alta porosidad, partiendo de una masa de polvos en condiciones de imponderabilidad. La consolidación de la estructura particular se realiza preferentemente de manera cuasi-instantánea. Entre las ventajas del método, destacan la amplia variedad de materiales que pueden tratarse, el amplio rango de porosidades que pueden alcanzarse, su bajo consumo de energía, y, en el caso de sinterización por descarga eléctrica, la funcionalización por alineamiento de la porosidad.
Patent ES-2634914-B2 (ES)
Title: Sistema de ventilación para fachada ventilada de junta cerrada
Inventor: SANTA CRUZ ASTORQUI JAIME
IPC: E04B1/76
Filed: 2016-03-29
Granted: 2018-06-15
Abstract: Sistema de ventilación para fachada ventilada de junta cerrada, con una capa de fábrica de soporte (15), una capa de aislamiento (3) y una capa exterior (4) de la fachada, que comprende una doble cámara de ventilación entre la capa exterior (4) y la capa de aislamiento (3), formada por una primera cámara (1) situada de forma adyacente a la capa exterior (4), una segunda cámara (2) situada de forma adyacente a la capa de aislamiento (3) y una membrana aislante (7) de separación de las mismas, y al menos un dispositivo de admisión y expulsión (6) de aire dispuesto en la fachada, donde dicho al menos un dispositivo de admisión y expulsión (6) está situado en la coronación del peto de cubierta y sobre la doble cámara de ventilación, donde la primera y la segunda cámaras (1, 2) están comunicadas en la zona inferior de las mismas.
Patent AU-2002236495-B2 (AU)
Title: Intraocular implants for preventing transplant rejection in the eye
Inventor: WONG VERNON G
IPC: A61K31/715
Filed: 2001-11-28
Granted: 2006-05-11
Abstract: Methods for reducing or preventing transplant rejection in the eye of an individual are described; comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Patent AU-2002246865-B2 (AU)
Title: Magnetic field furnace and a method of using the same to manufacture semiconductor substrates
Inventor: GLAVISH HILTON F
IPC: C30B29/06
Filed: 2001-12-28
Granted: 2006-11-09
Abstract: An apparatus and method is provided for manufacturing a semiconductor substrate such as web crystals. The apparatus includes a chamber and a growth hardware assembly housed within the chamber. A magnetic field system produces a vertical magnetic field within the chamber.
Patent AU-2002319111-B2 (AU)
Title: A catheter assembly
Inventor: TANGHOJ ALLAN
IPC: A61M25/16
Filed: 2002-06-28
Granted: 2008-09-18
Abstract: The present invention is a catheter assembly allowing for non-contaminated insertion of a catheter into a urinarycanal. The assembly includes a package for the catheter and an applicator to be used for guiding the catheter into the urinary canal without touching the catheter by holding the catheter via walls of the applicator. The assembly further comprises clamping means for pressing the walls of the applicator into engagement with the catheter. The present invention further relates to an applicator with integrated clamping means to be used with the assembly.
Patent AU-2002324756-B2 (AU)
Title: Mullerian inhibiting substance levels and ovarian response
Inventor: MACLAUGHLIN DAVID T
IPC: G01N33/53
Filed: 2002-08-20
Granted: 2008-08-07
Abstract: Methods and kits are provided for assessing the ovarian reserve and predicting the ovarian response to fertility treatments in a female subject. The serum levels of MIS are shown to be positively correlated with the production and retrieval of mature oocytes and serve as prognostic indicators for the female response to fertility treatment. The MIS levels can be monitored prior to and during fertility treatment and are useful to adjust the timing and dosage of treatments in order to produce optimal outcome in individual patients, to avoid ovarian hyperstimulation, or to indicate cancellation of an unsuccessful treatment. MIS can also be administered to women to stimulate follicle development and to prevent depletion of ovarian reserve.
Patent AU-2002326292-B2 (AU)
Title: Integrated inertial VMS navigation with inertial odometer correction
Inventor: MORGAN KENNETH S
IPC: G01C21/16
Filed: 2002-03-05
Granted: 2005-06-09
Abstract: A system for determining accurate inertial navigation data of a vehicle while moving must compensate for the orientation differences between an upper body and a lower body of the vehicle. These orientation differences are used to increase the accuracy of the aided inertial navigation solution. An odometer on the lower body is used to reduced errors in the inertial date arising from movement between the upper and low bodies and errors in the odometer associated with vehicle pitch are reduced by sensing pitch changes with the inertial navigation data.